Психопатологическая структура апатической депрессии

131. Canadian Psychiatric Association. Clinical Guidelines for the treatment of depressive disorders // Can. J. Psychiatry. 2001. Vol. 46. Suppl. 1. P. 1–90.

132. Carpenter W. T., Heinrichs D. W., Alphs L. D. Treatment of negative symptoms // Schizophr. Bull. 1985. Vol.11 (3). P.440–452.

133. Cassano G. B., Musetti L., Perugi G. et al. A proposed new approach to the clinical subclassification of depressive illness // Pharmacopsychiatry. 1988. Vol. 21 (1). P.19–23.

134. Choi S. H., Na D. L., Kwon H. M. et al. The Korean version of the neuropsychiatric inventory: a scoring tool for neuropsychiatric disturbance in dementia patients // J. Korean Med. Sci. 2000. Vol.15 (6). P.609–615.

135. Claxton A. J., Li Z., McKendrick J. Selective serotonin reuptake inhibitor treatment in the UK: risk of relapse or recurrence of depression // Br. J. Psychiatry. 2000. Vol. 177. P. 163–168.

136. Conrad K. The problem of «nosological unity» in psychiatry // Nervenarzt. 1959. Vol.30. P.488–494.

137. Cowen P. J. Pharmacological management of treatment-resistant depression // Adv. Psychiatr. Treatment. 1998. Vol. 4. P. 320–327.

138. Danzon M. Mental health: facing the challenges, building solutions: report from the WHO European Ministerial Conference, 2006.

139. Deniker P. Clinical forms & diagnosis of thymic psychoses; questionnaire // Encephale. 1957. Vol.46 (1). P.19–25.

140. Depont F., Rambelomanana S., Puil S. et al. Antidepressants: psychiatrists’ opinions and clinical practice // Acta Psychiatr. Scand. 2003. Vol. 108. P. 24–31.

141. Derouesne C., Lacomblez L. Depression and dementia // Psychol. Neuropsychiatr. Vieil. 2004. Vol.2. Suppl.1. P.35–42.

142. Desjarlais R., Eisenberg L., Good B. et al. World mental health: problems and priorities in low-income countries. NY: Oxford university press, 1995.

143. Donoghue J. M. Sub-optimal use of tricyclic antidepressants in primary care // Acta Psychiatr. Scand. 1998. Vol. 98. Р. 429–431.

144. Donoghue J. M., Tylee A. The treatment of depression: prescribing patterns of antidepressants in primary care in the UK // Br. J. Psychiatry. 1996. Vol. 168. P. 164–168.

145. Duffy J. Apathy in neurologic disorders // Curr. Psychiatry Rep. 2000. Vol. 2. P.434–439.

146. Ernst E., Gerada C., Hood S., Nutt D. A depressed man requesting St John’s wort // Practitioner. 1999. Vol.243 (1604). P.779–782.

147. Ey H. Etudes Psychiatriques. Desclée de Brouwer t.I, 1948, 296 pages; t. II, 1950, 550 p.; t. III, 1954. Réédité en 2 volumes et un CDRom, Préface Patrice Belzeaux et Jean Garrabé, éd. CREHEY, Cercle de Recherche et d’Édition Henri Ey, 2007.

148. Falret J. Folie circular // Bull. Acad. Nat. Med. 1853–1854. Vol.19. P. 356.

149. Fava M., Rankin M. A., Wright E. C. et al. Anxiety disorders in major depression // Compr. Psychiatry. 2000. Vol. 41. P. 97–102.

150. Finset A., Andersson S. Coping strategies in patients with acquired brain injury: relationships between coping, apathy, depression and lesion location // Brain Inj. 2000. Vol.14. P.887–905.

151. Furukawa T. A., Kitamara T., Takashishi K. Time to recovery of an inception cohort with hither to untreated unipolar major depressive episodes // Br. J. Psychiatry. – 2000. – Vol. 177. – P. 331–335.

152. Glatzel J. Allgemeine Psychopathologie. Stuttgart: Ferdinand Enke Verlag, 1978.

153. Glatzel J., Huber G. Zur Phanomenologie eines Types endogener juvenil-astenischer Versagensyndrome // Psychiatr. Clin. 1968. № 1. P.13–31.

154. Glozier N. Workplace effects of the stigmatization of depression // J. Occup. Environ. Med. 1998. Vol. 40. P. 793–800.

155. Guse S. B., Robins E. Suicide and primary affective disorders // British Journal of Psychiatry. 1970. Vol. 117. P.437–448.

156. Haddad P. M. Social and economic aspects of depression // WPA Teaching Bull. 1995. Vol. 2. № 8. P. 1–2.

157. Hall R. C. W., Wise M. G. The clinical and financial burden of mood disorders cost and outcome // Psychosomatics. 1995. Vol. 9. P. 195–201.

158. Hamilton M. A rating scale for depression // J. Neural. Neurosurg. Psychiatry. 1960. Vol.23. P. 56–62.

159. Hamilton M. Frequency of symptoms in melancholia (depressive illness) // Br. J. Psychiatry. 1989. Vol.154. P.201–206.

160. Hamilton M. The clinical distinction between anxiety and depression // The borderline between anxiety and depression. Medidact., Leusden, Netherland, 1988. P.11–21.

161. Hirschfeld R. M., Keller M. B., Panico S. et al. The national depressive and manic-depressive association consensus statement on the undertreatment of depression // JAMA. 1997. Vol. 277. P. 333–340.

162. Hirschfeld R. M. WPA. Teaching Bulletin on Depression. 2000. Vol. 4. № 19. P. 7–10.

163. Hotopf M., Lewis G., Normand C. Are SSRIs a cost-effective alternative to tricyclics? // Br. J. Psychiatry. 1996. Vol. 168. P. 404–409.

164. Janzarick K. Problem der strukturell-dynamisschen Koharenz in der Zyklothymieforschung // Hervenarzt. 1974. Bd.45. P.623–638.